{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:40Z","timestamp":1786982380407,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["95531573"],"award-info":[{"award-number":["95531573"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12325-025-03346-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:40:54Z","timestamp":1759754454000},"page":"6045-6058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Global Patient Perspective on Uncontrolled Moderate-to-Severe Asthma: Reducing Delays in Diagnosis and Treatment"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2682-7281","authenticated-orcid":false,"given":"Karen","family":"Rance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"McCreary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Urrutia-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Willard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Winders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tal-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"3346_CR1","doi-asserted-by":"publisher","DOI":"10.7189\/JOGH.12.04052","author":"P Song","year":"2022","unstructured":"Song P, Adeloye D, Salim H, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health. 2022. https:\/\/doi.org\/10.7189\/JOGH.12.04052.","journal-title":"J Glob Health"},{"issue":"1","key":"3346_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5334\/aogh.2412","volume":"85","author":"O Enilari","year":"2019","unstructured":"Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1):1\u20137. https:\/\/doi.org\/10.5334\/aogh.2412.","journal-title":"Ann Glob Health"},{"key":"3346_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5588\/ijtld.22.1010","volume":"26","author":"B Mikkelsen","year":"2022","unstructured":"Mikkelsen B. The global asthma report 2022. Int J Tuberc Lung Dis. 2022;26:20\u201323. https:\/\/doi.org\/10.5588\/ijtld.22.1010.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3346_CR4","unstructured":"2024 GINA main report: global strategy for asthma management and prevention. Published 2024. Accessed 30 May 2025."},{"issue":"10","key":"3346_CR5","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, et al. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;36(10):3179\u201387. https:\/\/doi.org\/10.1007\/s11606-021-06737-1.","journal-title":"J Gen Intern Med"},{"issue":"8","key":"3346_CR6","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jaip.2022.04.025","volume":"10","author":"CD Codispoti","year":"2022","unstructured":"Codispoti CD, Greenhawt M, Oppenheimer J. The role of access and cost-effectiveness in managing asthma: a systematic review. J Allergy Clin Immunol Pract. 2022;10(8):2109\u201316. https:\/\/doi.org\/10.1016\/j.jaip.2022.04.025.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"15","key":"3346_CR7","first-page":"2","volume":"64","author":"H Pinnock","year":"2017","unstructured":"Pinnock H, Parke H, Panagioti M, et al. Systematic meta-review of supported self management for asthma: a healthcare perspective. BMC Med. 2017;64(15):2.","journal-title":"BMC Med"},{"key":"3346_CR8","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1038\/npjpcrm.2014.9","volume":"24","author":"D Price","year":"2014","unstructured":"Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise asthma and LInk to symptoms and experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009.","journal-title":"NPJ Prim Care Respir Med"},{"key":"3346_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13601-019-0279-2","volume":"9","author":"J Bousquet","year":"2019","unstructured":"Bousquet J, Schunemann H, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Tranl Allergy. 2019;9:44.","journal-title":"Clin Tranl Allergy"},{"key":"3346_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.022","author":"O Osazuwa-Peters","year":"2022","unstructured":"Osazuwa-Peters O, Greiner M, Oberle A, et al. Factors related to biologic adherence and outcomes among moderate-to-severe asthma patients. J Allergy Clin Immunol Pract. 2022. https:\/\/doi.org\/10.1016\/j.jaip.2022.05.022.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3346_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2147\/PPA.S517466","volume":"19","author":"R Tal-Singer","year":"2025","unstructured":"Tal-Singer R, Willard KS, Luttmann MA, et al. Disease impact and perception of biologics in adults with type 2 inflammatory respiratory disease: international survey result. Patient Prefer Adherence. 2025;19:1159\u201370.","journal-title":"Patient Prefer Adherence"},{"key":"3346_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.2147\/JAA.S468068","volume":"17","author":"T Le","year":"2024","unstructured":"Le T, Price D, Erhard C, et al. Disease burden and access to biologic therapy in patients with severe asthma, 2017\u2013222: an analysis of the international severe asthma registry. J Asthma Allergy. 2024;17:1056.","journal-title":"J Asthma Allergy"},{"key":"3346_CR13","doi-asserted-by":"publisher","first-page":"2103179","DOI":"10.1183\/13993003.03179-2021","volume":"60","author":"K Mortimer","year":"2022","unstructured":"Mortimer K, Reddel HK, Pitrez PM, et al. Asthma management in low and middle income countries: case for change. Eur Respir J. 2022;60:2103179. https:\/\/doi.org\/10.1183\/13993003.03179-2021.","journal-title":"Eur Respir J"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03346-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03346-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:04:05Z","timestamp":1763132645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03346-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3346"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03346-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karen Rance, Brenda Young, Gretchen McCreary, Stephanie Williams, Kristen Willard, and Ghulam Mustafa, as well as Marilyn Urrutia Pereira, have no disclosures to report. Purvi Parikh is a speaker for Genentech. Tonya Winders is a paid advisor and speaker for AstraZeneca, Chiesi, GSK, Novartis, Roche, and Sanofi Regeneron. Ruth Tal-Singer is a shareholder of GSK and holds share options in ENA Respiratory and reports personal fees from AstraZeneca, Boehringer Ingelheim, ENA Respiratory, Janssen, Roche, Vocalis Health, Teva, ImmunoMet, Renovion, Samay Health, GSK, ItayAndBeyond, COPD Foundation, and GlobalSkin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The United States-based research team received an exemption for the English version of the survey, recruitment text, images, and consent form from a central institutional review board (BRANY, Lake Success, NY), granted an exempt determination for the English version of the survey, recruitment text, images. No incentives were provided for survey participation. The study adhered to the ethical principles outlined in the Declaration of Helsinki and followed the Consensus-Based Checklist for Reporting of Survey Studies (CROSS) [\n                      \n                      ]. The survey was administered electronically and included a mix of multiple-choice, Likert scale, and open-ended questions to gather both quantitative and qualitative data. All participants provided electronic consent prior to beginning the survey, during which the study\u2019s purpose, procedures, and other relevant details were clearly explained. Participation was voluntary, with the option to withdraw any time.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}